Scolaris Content Display Scolaris Content Display

Physical exercise training for cystic fibrosis

This is not the most recent version

Abstract

available in

Background

Physical exercise training may form an important part of regular care for people with cystic fibrosis. This is an update of a previously published review.

Objectives

To assess the effects of physical exercise training on exercise capacity by peak oxygen consumption, pulmonary function by forced expiratory volume in one second, health‐related quality of life and further important patient‐relevant outcomes in people with cystic fibrosis.

Search methods

We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register which comprises references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings.

Date of the most recent search: 04 May 2017.

We searched ongoing trials registers (clinicaltrials.gov and the WHO ICTRP). Date of most recent search: 10 August 2017.

Selection criteria

All randomised and quasi‐randomised controlled clinical trials comparing exercise training of any type and a minimum duration of two weeks with conventional care (no training) in people with cystic fibrosis.

Data collection and analysis

Two authors independently selected studies for inclusion, assessed methodological quality and extracted data. The quality of the evidence was assessed using the GRADE system.

Main results

Of the 83 studies identified, 15 studies which included 487 participants, met the inclusion criteria. The numbers in each study ranged from nine up to 72 participants; two studies were in adults, seven were in children and adolescents and six studies included all age ranges. Four studies of hospitalised participants lasted less than one month and 11 studies were outpatient‐based, lasting between two months and three years. The studies included participants with a wide range of disease severity and employed differing levels of supervision with a mixture of types of training. There was also wide variation in the quality of the included studies.

This systematic review shows very low‐ to low‐quality evidence from both short‐ and long‐term studies that in people with cystic fibrosis aerobic or anaerobic physical exercise training (or a combination of both) has a positive effect on aerobic exercise capacity, pulmonary function and health‐related quality of life. No study reported on mortality; two studies reported on adverse events (moderate‐quality evidence); one of each study reported on pulmonary exacerbations (low‐quality evidence) and diabetic control (very low‐quality evidence). Although improvements were not consistent between studies and ranged from no effects to clearly positive effects, the most consistent effects of the heterogeneous exercise training modalities and durations were found for maximal aerobic exercise capacity (in four out of seven studies) with unclear effects on forced expiratory volume in one second (in two out of 11 studies) and health‐related quality of life (in two out of seven studies).

Authors' conclusions

Evidence about the efficacy of physical exercise training in cystic fibrosis from 15 small studies with low to moderate methodological quality is limited. Exercise training is already part of regular outpatient care offered to most people with cystic fibrosis, and since there is some evidence for beneficial effects on aerobic fitness and no negative side effects exist, there is no reason to actively discourage this. The benefits from including physical exercise training in an individual's regular care may be influenced by the type and duration of the training programme. High‐quality randomised controlled trials are needed to comprehensively assess the benefits of exercise programmes in people with cystic fibrosis and the relative benefits of the addition of aerobic versus anaerobic versus a combination of both types of physical exercise training to the care of people with cystic fibrosis.

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.

Plain language summary

Physical training to improve exercise capacity in people with cystic fibrosis

Review question

We reviewed the evidence about whether physical exercise training improves low aerobic fitness, improves health‐related quality of life and slows the decline in lung function in people with cystic fibrosis (CF). This is an update of a previously published review.

Background

CF affects many systems in the body, but mainly the lungs. It causes shortness of breath and limits the amount of exercise people with the condition can tolerate. The progress of lung disease leads to a low ability to exercise and physical inactivity, which in turn affects health and health‐related quality of life. We looked for studies where people with CF of any age did aerobic training (continuous activity at a low to moderate intensity, such as jogging, cycling, swimming or walking) or anaerobic training (weight or resistance training or sprinting at a high intensity for a short duration) or a combination of both compared to no training.

Search date

The evidence is current to: 04 May 2017.

Study characteristics

This review includes 15 studies with a total of 487 people with CF; the numbers in each study ranged from just nine people up to 72 people in the largest study. Two studies were in adults, seven were in children and adolescents and six studies included all age ranges. Four studies lasted less than one month and took place while the participants were in hospital; 11 studies were outpatient‐based and lasted from two months up to three years. The studies included people with a wide range of severity of CF lung disease. There were differing levels of supervision in the studies and a mixture of types of training.

The outcome most often reported in the studies was the change in lung function; other commonly reported outcomes included peak oxygen consumption, health‐related quality of life, change in muscle strength and change in body composition (e.g. muscle and fat).

Key results

Due to different study designs (type of exercise training, duration, etc.), we could not combine results from different studies. The short‐term studies did not show differences between treatments. The longer studies showed that physical exercise training can improve aerobic capacity, there were some improvements in lung function and health‐related quality of life, but these were not consistent across all studies. No study reported the number of deaths; two studies reported on side effects; one study reported on pulmonary exacerbations and another on diabetic control.

Quality of the evidence

We included a number of small studies and thought the quality of these studies was moderate at best (only for side effects). Overall, there was only low‐ to very low‐quality evidence that aerobic or anaerobic physical exercise training (or a combination of both) has a positive effect on aerobic exercise capacity, pulmonary function and health‐related quality of life in people with CF. In four of the studies the participant characteristics at the start of the studies were different between groups, despite being put into the different treatment groups at random. It is not possible for people not to know which treatment group they are in when comparing exercise training to no exercise. However, we do not think the fact that people knew which treatment they were receiving would affect the results for lung function as long as the assessments were done properly. In contrast, there may be bias when the people assessing an individual's cardiopulmonary fitness are not blinded to which group the volunteer is in. In less than half of the included studies, the investigators tried to prevent the outcome assessors from knowing which groups the participants were in; and in only one study was the lead researcher blinded. The studies did not routinely measure health‐related quality of life and where it was measured, different measurement tools were used. Selective reporting of results maybe an issue, especially as most of the included studies were not listed in trial registries, which give advance details of the outcomes being measured. We are uncertain about the effects and further better quality studies will likely change these findings.